Last month, Evotec entered into a multi-year collaboration deal with Pfizer PFE. Per the deal terms, this partnership with Pfizer will focus on early discovery research for metabolic and ...

Last month, Evotec entered into a multi-year collaboration deal with Pfizer PFE. Per the deal terms, this partnership with Pfizer will focus on early discovery research for metabolic and infectious ...

German life science company Evotec is cutting 400 jobs as the company continues to deal with ‘a more difficult market environment'.” The company’s CEO Christian Wojczewski has announced an ...

In July, Evotec signed a metabolic- and infectious-disease-focused agreement with Pfizer. For the first half of the year, Evotec saw group revenues increase 2% year over year to 390.8 million ...

HAMBURG, GERMANY / ACCESSWIRE / August 14, 2024 / Evotec SE (Frankfurt Stock Exchange ... including option and license agreement with Pfizer, initially focusing on early discovery research for ...

The stock market seems to be at a crossroads. The major market indexes remain near record highs. However, there's been more volatility this earnings season, including some heavy selling of ...

Evotec expressly disclaims any obligations or undertaking to ... including option and license agreement with Pfizer, initially focusing on early discovery research for metabolic and infectious ...